Cargando…
Plecanatide: a new guanylate cyclase agonist for the treatment of chronic idiopathic constipation
Chronic constipation affects millions of Americans, consumes significant healthcare resources, and significantly affects quality of life (QOL). Recently, several new treatment options have become available for the treatment of constipation, including intestinal secretagogues such as lubiprotone, and...
Autor principal: | Rao, Satish S.C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6009086/ https://www.ncbi.nlm.nih.gov/pubmed/29942351 http://dx.doi.org/10.1177/1756284818777945 |
Ejemplares similares
-
Profile of plecanatide in the treatment of chronic idiopathic constipation: design, development, and place in therapy
por: Sharma, Amol, et al.
Publicado: (2019) -
Influence of Demographic Factors on Clinical Outcomes in Adults With Chronic Idiopathic Constipation Treated With Plecanatide
por: Rao, Satish S.C., et al.
Publicado: (2023) -
Clinical utility of plecanatide in the treatment of chronic idiopathic constipation
por: Islam, Bianca N, et al.
Publicado: (2018) -
Therapeutically targeting guanylate cyclase‐C: computational modeling of plecanatide, a uroguanylin analog
por: Brancale, Andrea, et al.
Publicado: (2017) -
Randomized clinical trial: efficacy and safety of plecanatide in the treatment of chronic idiopathic constipation
por: DeMicco, Michael, et al.
Publicado: (2017)